Dialysis dose in end-stage renal disease patients undergoing regular hemodialysis at Ibn-Sena and AlNao hospitals in Sudan
Introduction: Ne Hemodialysis (HD) plays a fundamental role in the treatment of end-stage renal disease (ESRD) patients. A minimal duration between 9 to 12 hours per week is required for maintaining adequate HD to restore excretory function of the kidney. Objectives: To measure the average dura...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Diabetic Nephropathy Prevention
2020-01-01
|
| Series: | Journal of Nephropharmacology |
| Subjects: | |
| Online Access: | http://jnephropharmacology.com/PDF/npj-1296 |
| _version_ | 1818568859104313344 |
|---|---|
| author | Essamaddin A Ibrahim |
| author_facet | Essamaddin A Ibrahim |
| author_sort | Essamaddin A Ibrahim |
| collection | DOAJ |
| description | Introduction: Ne Hemodialysis (HD) plays a fundamental role in the treatment of end-stage renal disease (ESRD) patients. A minimal duration between 9 to 12 hours per week is required for maintaining adequate HD to restore excretory function of the kidney. Objectives: To measure the average duration of HD among Sudanese patients, and compare with the universal recommended duration. Patients and Methods: A cross-sectional, descriptive study at IBN-SENA hospital and ALNAO teaching hospital was conducted. All patients were subjected to full medical history and examination to identify their age, gender, original kidney disease and duration and route of HD. Results: A total of 121 ESRD patients under regular HD participated in this study. The majority [78 (64.5%)] had an average duration of HD of 8 h/wk. Conclusion: A large proportion of our patients on HD are below target dialysis dose; mainly due to reducing in the number of sessions per week and average duration per each session. |
| first_indexed | 2024-12-14T06:40:36Z |
| format | Article |
| id | doaj.art-08336763dbb64d8e967edaba677fcebc |
| institution | Directory Open Access Journal |
| issn | 2345-4202 |
| language | English |
| last_indexed | 2024-12-14T06:40:36Z |
| publishDate | 2020-01-01 |
| publisher | Society of Diabetic Nephropathy Prevention |
| record_format | Article |
| series | Journal of Nephropharmacology |
| spelling | doaj.art-08336763dbb64d8e967edaba677fcebc2022-12-21T23:13:13ZengSociety of Diabetic Nephropathy PreventionJournal of Nephropharmacology2345-42022020-01-0191e10e1010.15171/npj.2020.10npj-1296Dialysis dose in end-stage renal disease patients undergoing regular hemodialysis at Ibn-Sena and AlNao hospitals in SudanEssamaddin A Ibrahim0Department of Internal Medicine, University of Science and TechnologyIntroduction: Ne Hemodialysis (HD) plays a fundamental role in the treatment of end-stage renal disease (ESRD) patients. A minimal duration between 9 to 12 hours per week is required for maintaining adequate HD to restore excretory function of the kidney. Objectives: To measure the average duration of HD among Sudanese patients, and compare with the universal recommended duration. Patients and Methods: A cross-sectional, descriptive study at IBN-SENA hospital and ALNAO teaching hospital was conducted. All patients were subjected to full medical history and examination to identify their age, gender, original kidney disease and duration and route of HD. Results: A total of 121 ESRD patients under regular HD participated in this study. The majority [78 (64.5%)] had an average duration of HD of 8 h/wk. Conclusion: A large proportion of our patients on HD are below target dialysis dose; mainly due to reducing in the number of sessions per week and average duration per each session.http://jnephropharmacology.com/PDF/npj-1296End stage renal diseaseHemodialysisChronic kidney diseaseGlomerular filtration rateVascular accessRenal replacement therapy |
| spellingShingle | Essamaddin A Ibrahim Dialysis dose in end-stage renal disease patients undergoing regular hemodialysis at Ibn-Sena and AlNao hospitals in Sudan Journal of Nephropharmacology End stage renal disease Hemodialysis Chronic kidney disease Glomerular filtration rate Vascular access Renal replacement therapy |
| title | Dialysis dose in end-stage renal disease patients undergoing regular hemodialysis at Ibn-Sena and AlNao hospitals in Sudan |
| title_full | Dialysis dose in end-stage renal disease patients undergoing regular hemodialysis at Ibn-Sena and AlNao hospitals in Sudan |
| title_fullStr | Dialysis dose in end-stage renal disease patients undergoing regular hemodialysis at Ibn-Sena and AlNao hospitals in Sudan |
| title_full_unstemmed | Dialysis dose in end-stage renal disease patients undergoing regular hemodialysis at Ibn-Sena and AlNao hospitals in Sudan |
| title_short | Dialysis dose in end-stage renal disease patients undergoing regular hemodialysis at Ibn-Sena and AlNao hospitals in Sudan |
| title_sort | dialysis dose in end stage renal disease patients undergoing regular hemodialysis at ibn sena and alnao hospitals in sudan |
| topic | End stage renal disease Hemodialysis Chronic kidney disease Glomerular filtration rate Vascular access Renal replacement therapy |
| url | http://jnephropharmacology.com/PDF/npj-1296 |
| work_keys_str_mv | AT essamaddinaibrahim dialysisdoseinendstagerenaldiseasepatientsundergoingregularhemodialysisatibnsenaandalnaohospitalsinsudan |